Bath & Body Works financials
$15.99−1.24%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '27 Aug 1 | Q1 '27 May 2 | Q4 '26 Jan 31 | Q3 '26 Nov 1 | Q2 '26 Aug 2 | Q1 '26 May 3 | Q4 '25 Feb 1 | Q3 '25 Nov 2 | Q2 '25 Aug 3 | Q1 '25 May 4 | Q4 '24 Feb 3 | Q3 '24 Oct 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.51B | $1.38B | $2.72B | $1.59B | $1.55B | $1.42B | $2.79B | $1.61B | $1.53B | $1.38B | $2.91B | $1.56B |
| Gross profit | $692.0M | $587.0M | $1.24B | $658.0M | $640.0M | $646.0M | $1.30B | $700.0M | $626.0M | $606.0M | $1.34B | $682.0M |
| Gross margin | 45.7% | 42.6% | 45.7% | 41.3% | 41.3% | 45.4% | 46.7% | 43.5% | 41.0% | 43.8% | 45.9% | 43.7% |
| Operating income | $216.0M | $231.0M | $599.0M | $161.0M | $157.0M | $209.0M | $678.0M | $218.0M | $183.0M | $187.0M | $696.0M | $221.0M |
| Net income | $118.0M | $183.0M | $403.0M | $77.0M | $64.0M | $105.0M | $453.0M | $106.0M | $152.0M | $87.0M | $579.0M | $119.0M |
| Net margin | 7.8% | 13.3% | 14.8% | 4.8% | 4.1% | 7.4% | 16.3% | 6.6% | 10.0% | 6.3% | 19.9% | 7.6% |
| Diluted EPS | $0.58 | $0.90 | $1.98 | $0.37 | $0.30 | $0.49 | $2.10 | $0.49 | $0.68 | $0.38 | $2.53 | $0.52 |
| EBITDA | $275.0M | $292.0M | $662.0M | $224.0M | $221.0M | $273.0M | $749.0M | $287.0M | $254.0M | $258.0M | $696.0M | $291.0M |
| Operating cash flow | $72.0M | $244.0M | $877.0M | $80.0M | -$43.0M | $188.0M | $955.0M | -$99.0M | -$46.0M | $76.0M | $926.0M | -$49.0M |
| Free cash flow | $23.0M | $195.0M | $814.0M | -$1.0M | -$99.0M | $151.0M | $895.0M | -$164.0M | -$101.0M | $30.0M | $878.0M | -$121.0M |
| Diluted shares | 202.0M | 202.0M | 204.0M | 206.0M | 211.0M | 215.0M | 216.0M | 219.0M | 223.0M | 226.0M | 229.0M | 228.0M |
Balance sheet
| Period end | Aug 1 | May 2 | Jan 31 | Nov 1 | Aug 2 | May 3 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $794.0M | $820.0M | $953.0M | $236.0M | $364.0M | $636.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $3.61B | $3.61B | $3.89B | $3.89B | $3.89B | $3.89B |
| Total assets | $5.16B | $4.96B | $5.07B | $4.99B | $4.81B | $4.88B |
| Total liabilities | $6.21B | $6.09B | $6.35B | $6.58B | $6.36B | $6.33B |
| Shareholders' equity | -$1.05B | -$1.13B | -$1.28B | -$1.59B | -$1.55B | -$1.45B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology